Several key findings stand out
Atorvastatin in combination with narrowband UV-B in adult patients with active vitiligo: a randomized clinical trial
PTX affords a potent gastroprotection against these lesions, an effect probably associated with the suppression of proinflammatory cytokines, reduction of lipid peroxidation as well as increase of the antioxidative enzymes, including the SOD activity and increased GSH mucosal concentration
This initial period lets your body adapt to the medication gradually
These data were first presented by Amanda Johnson, MD, Mayo Clinic, Rochester, Minnesota, at the 2026 Crohns and Colitis Congress on Friday, January 23, 2026, in Las Vegas, Nevada
Pakhale S, Baron J, Dent R, et al